Beckman Coulter continues to pay attention to the development of the coagulation market, and recently launched a strategic cooperation with Accurdx in the field of intelligent coagulation, setting another milestone in localization innovation.

Dublin-based diagnostics firm Trinity Biotech on Thursday reported a 61 percent year-over-year increase in second quarter revenues, driven in part by sales of its PCR viral transport media for SARS-CoV-2 testing.

The Japan Ministry of Health, Labour and Welfare (MHLW), Japan's regulatory agency, has granted approval to the Thermo Fisher Scientific's Oncomine Dx Target Test to be used as a companion diagnostic to identify patients with RET-fusion positive non-small cell lung cancer (NSCLC).

On September 13, 2021, Shanghai Labway Medical Laboratory Co., Ltd. was listed on Shenzhen Stock Exchange (SZSE) ChiNext. Stock code: 688622. The number of new shares publicly issued this time is 48.062 million shares, the issue price is CNY4.17/share, and the opening price is CNY18.25/share.

On September 13, 2021, Guangzhou Hexin Instrument Co., Ltd. (hereinafter referred to as " Hexin") was listed on SSE STAR Market. Stock code: 688622. The number of A shares publicly issued this time is 17.5 million shares, the issue price is CNY 17.7/share, and the opening price is CNY 92.11 /share.

Life science company RareCyte said on Thursday that it completed $24 million in financing from both new and existing investors.

PerkinElmer said on Wednesday that it has priced an offering of senior notes totaling $2.3 billion, providing the company with funds to help complete its planned acquisition of BioLegend.

Siemens Healthineers on Thursday announced a collaboration with A1 Life Sciences to offer an evolving portfolio of PCR-based assays for the identification of SARS-CoV-2 mutations and variants.

Roche announced on Thursday that it has entered a share purchase agreement to acquire 100 percent of the outstanding shares of the TIB Molbiol Group.

On September 9, 2021, Agilent successfully delivered the first batch of SureSelect targeted capture probe products produced in China at its Hangzhou production base.

Foundation Medicine announced on Wednesday that it is collaborating with Science 37 to create a home-based clinical trial model for patients who can't travel to clinical trial sites.

Alamar Biosciences said on Wednesday that it has closed an $80 million Series B financing round, bringing its total funding to $110 million.

On September 8, 2021, Hangzhou Biotest Biotech Co., Ltd. was listed on SSE STAR Market. Stock code: 688767. The issue price is 34.55 yuan/share, and the opening price is 80.50 yuan/share.

Siemens Healthineers said Tuesday that the TüV Rheinland certification agency has certified its first products under the new European In Vitro Diagnostic Regulation.

Illumina and Merck provided more details on Tuesday about their partnership to develop and commercialize tests that gauge genetic mutations involved in homologous recombination deficiency, or HRD, and identify best responders to PARP inhibitors.